N-Acetylmescaline
Pharmaceutical compound
From Wikipedia, the free encyclopedia
N-Acetylmescaline, also known as mescaline acetamide or as N-acetyl-3,4,5-trimethoxyphenethylamine, is a mescaline derivative found in trace quantities in peyote (Lophophora williamsii).[1][2][3] It is a minor metabolite of mescaline in humans, but has little pharmacological activity of its own.[2][4] At doses of 306 to 756 mg orally, only mild drowsiness was observed at the highest dose.[2][4][5][3][6][7] Hence, N-acetylmescaline appears to be inactive as a hallucinogen.[5] N-Acetylmescaline has microtubule assembly inhibitory activity.[8] The chemical synthesis of N-acetylmescaline has been described.[2] N-Acetylmescaline was isolated and first synthesized by Ernst Späth and Johann Bruck and was described by them in the scientific literature in 1938.[3][9]
| Clinical data | |
|---|---|
| Other names | NAM; Mescaline acetamide; N-Acetyl-3,4,5-trimethoxyphenethylamine |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C13H19NO4 |
| Molar mass | 253.298 g·mol−1 |
| 3D model (JSmol) | |
| Melting point | 93 to 94 °C (199 to 201 °F) [1] |
| |
| |